Althea Group Holdings operates in the medicinal cannabis industry and through its strategic partnerships and current and prospective regulatory licenses and permits, aims to become a leading and trusted medicinal cannabis brand globally.
Althea has been granted all required Office of Drug Control (ODC) licenses including Cultivation, Manufacturing and Export licenses. These licenses, coupled with Althea’s focus on patient care, underpins its business strategy.
Althea has entered into a number of strategic partnerships which have enabled Althea to begin importing and distributing Althea pharmaceutical grade medicinal cannabis products around the world. Althea generated its first sales to pharmacies for supply to eligible patients in Australia in May 2018.
Althea has also developed a complementary education and patient support service through its Althea Concierge web-based platform, which provides a simple pathway for healthcare professionals and patients to access information and support to help navigate the complexities of accessing and prescribing medicinal cannabis.
Althea Group Holdings has an experienced Board and highly skilled Management with relevant industry experience. Althea Group Holdings’ Board and Management are committed to capitalizing on the growth opportunities that are arising in the medicinal cannabis industry.